Brian A. Grabowski
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
-
- Gout, Hyperuricemia, Uric Acid 5
- Parathyroid Disorders and Treatments 1
- Co-authors
- Laurent Vernillet (6 shared papers)Reza Khosravan (6 shared papers)Jingtao Wu (4 shared papers)Jon F. Denissen (6 shared papers)Nancy Joseph‐Ridge (4 shared papers)Dale J. Kempf (4 shared papers)Samuel B. Thomas (3 shared papers)Gondi N. Kumar (4 shared papers)
- Journals
- Drug Metabolism and Disposition (3 papers)British Journal of Clinical Pharmacology (2 papers)The Journal of Clinical Pharmacology (2 papers)Nephron Clinical Practice (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Brian A. Grabowski
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 49
- Infectious Diseases 382
- Nephrology 191
- Pharmacology 114
- Pharmaceutical Science 45
- Analytical Chemistry 63
Countries citing papers authored by Brian A. Grabowski
This map shows the geographic impact of Brian A. Grabowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Grabowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Grabowski more than expected).
Fields of papers citing papers by Brian A. Grabowski
This network shows the impact of papers produced by Brian A. Grabowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Grabowski. The network helps show where Brian A. Grabowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian A. Grabowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 401 | |
| 2 | 1998 | 162 | |
| 3 | Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans. | 1997 | 116 |
| 4 | 2006 | 93 | |
| 5 | 2004 | 92 | |
| 6 | 2007 | 73 | |
| 7 | 2006 | 67 | |
| 8 | 1999 | 57 | |
| 9 | 2010 | 52 | |
| 10 | 2010 | 21 | |
| 11 | 1996 | 12 | |
| 12 | 1994 | 11 | |
| 13 | 2012 | 9 | |
| 14 | 2005 | 8 | |
| 15 | 2006 | 2 |
About Brian A. Grabowski
Brian A. Grabowski is a scholar working on Pharmacology, Nephrology, Infectious Diseases, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Gout, Hyperuricemia, Uric Acid (5 papers), HIV/AIDS drug development and treatment (2 papers) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Infectious Diseases (382 citations), Nephrology (191 citations), Pharmacology (114 citations), Pharmaceutical Science (45 citations) and Analytical Chemistry (63 citations). Brian A. Grabowski has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Laurent Vernillet, Reza Khosravan, Jingtao Wu, Jon F. Denissen, Nancy Joseph‐Ridge, Dale J. Kempf, Samuel B. Thomas, Gondi N. Kumar, Hing Leung Sham and Bruce Warren Surber. Their work appears in journals such as Drug Metabolism and Disposition, British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Nephron Clinical Practice and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.